Investor Update

Basel, 04 May 2010

Roche Investor Event: ASCO 2010

Analyst briefing on data presented at ASCO: Sunday, June 6

We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (June 4-8, 2010).


Palmer House Hilton
17 East Monroe Street
Chicago, IL 60603


Sunday, 6 June, 2010
6.30 pm to 8.00 pm Central Daylight time CDT (Chicago)
followed by a buffet reception


  • Setting the standard of care in oncology
    Pascal Soriot, COO Roche Pharmaceuticals
  • Avastin in ovarian cancer, GOG-0218 study data
    Jakob Dupont, M.D., M.A., Associate Group Medical Director, Avastin Global Clinical Development, Genentech
  • Overview of Avastin development program
    Stefan Frings, M.D., Ph.D., Avastin Franchise Director, Roche
  • MabThera/Rituxan maintenance in previously untreated patients with follicular lymphoma (PRIMA study)
    Gilles Salles, M.D., Ph.D., Principal Investigator of PRIMA study Centre Hospitalier Lyon-Sud, France
  • Overview of Roche/Genentech oncology pipeline
    Hal Barron, M.D., Executive Vice President, Global Development and Chief Medical Officer, Roche

Download Registration Form